DMKJ
REGN icon

David M. Knott Jr’s Regeneron Pharmaceuticals REGN Stock Holding History

David M. Knott Jr’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,000
Closed -$1.27M – 93
2025
Q1 		$1.27M Buy
+2,000
New +$1.38M 0.6% 26
2022
Q3 		– Sell
-2,500
Closed -$1.48M – 188
2022
Q2 		$1.48M Sell
2,500
-1,500
-38% -$975K 0.62% 42
2022
Q1 		$2.79M Sell
4,000
-2,000
-33% -$1.27M 0.89% 34
2021
Q4 		$3.79M Buy
+6,000
New +$3.69M 1.29% 20

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

David M. Knott Jr's REGN Position: Q2 2025 in Review

David M. Knott Jr sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 2,000 shares — an estimated $1.27M sold.

David M. Knott Jr first reported a position in REGN in Q4 2021 and held it in 4 quarters. The position peaked at $3.79M in Q4 2021. 1,202 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

  • David M. Knott Jr reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • David M. Knott Jr sold 2,000 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $1.27M.
  • David M. Knott Jr first reported a position in Regeneron Pharmaceuticals in Q4 2021 and held it in 4 quarters.
  • David M. Knott Jr's Regeneron Pharmaceuticals position peaked at $3.79M in Q4 2021.
  • 1,202 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on David M. Knott Jr's 13F filing for Q2 2025, filed 11 Aug 2025.